Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C20orf27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101060817 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SVIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SHCBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYRM7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM256 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC47A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGMAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKAR2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSE1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFB6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MESP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RACGAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on